Dachaigh › Aillse a' bhroilleach › Michigan › Ann Arbor
Sgrùdaidhean clionaigeach Aillse a' bhroilleach ann an Ann Arbor, MI
Tha 27 sgrùdaidhean airson Aillse a' bhroilleach a’ lorg phàirtichean aig làraichean ann agus timcheall air Ann Arbor (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
A’ fastadhÌre 3
- University of Michigan, Ann Arbor
A Study of PHST001 in Advanced Solid Tumors
A’ fastadhÌre 1
- University of Michigan Rogel Cancer Center, Ann Arbor
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mìle air falbh
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mìle air falbh
- agus 4 a bharrachd
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
A’ fastadhÌre 1/2
- University of Michigan, Ann Arbor
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
A’ fastadhÌre 2
- University of Michigan Rogel Cancer Center, Ann Arbor
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
A’ fastadhÌre 3
- Clinical Trial Site, Ann Arbor
A Phase 1/1b Study of IAM1363 in HER2 Cancers
A’ fastadhÌre 1
- University of Michigan, Ann Arbor
Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial
A’ fastadhÌre 3
- Trinity Health IHA - Obstetrics and Gynecology West Arbor, Ann Arbor
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
A’ fastadhSgrùdadh amharc
- Trinity Health, Ann Arbor
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
A’ fastadhÌre 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mìle air falbh
- agus 6 a bharrachd
E-Mindfulness Approaches for Living After Breast Cancer
A’ fastadhÌre 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
- University of Michigan Rogel Cancer Center, Ann Arbor
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
A’ fastadhÌre 2
- University of Michigan Rogel Cancer Center, Ann Arbor
Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer
A’ fastadhÌre 1
- University of Michigan, Ann Arbor
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
A’ fastadhÌre 4
- University of Michigan Rogel Cancer Center, Ann Arbor
Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial
A’ fastadhÌre 2
- University of Michigan Comprehensive Cancer Center, Ann Arbor
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
A’ fastadhÌre 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mìle air falbh
- agus 5 a bharrachd
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
A’ fastadhÌre 1/2
- Trinity Health, Ypsilanti · 7 mìle air falbh
CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer
A’ fastadh
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
A’ fastadhSgrùdadh amharc
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
A’ fastadh
- University of Michigan Comprehensive Cancer Center, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Ann Arbor
The Cancer of the Pancreas Screening-5 CAPS5)Study
A’ fastadhÌre 3
- University of Michigan, Ann Arbor
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
A’ fastadhÌre 3
- Saint Joseph Mercy Hospital, Ann Arbor
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mìle air falbh
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
A’ fastadhÌre 1/2
- University of Michigan, Ann Arbor
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
A’ fastadhÌre 1
- University of Michigan, Ann Arbor
CtDNA Based MRD Testing for NAC Monitoring in TNBC
A’ fastadhSgrùdadh amharc
- Trinity Health-Michigan, Ypsilanti · 7 mìle air falbh
Sgrùdaidhean Aillse a' bhroilleach ann am bailtean eile
- New York City, NY136 sgrùdaidhean
- Houston, TX126 sgrùdaidhean
- Boston, MA112 sgrùdaidhean
- Nashville, TN81 sgrùdaidhean
- Los Angeles, CA73 sgrùdaidhean
- Edison, NJ68 sgrùdaidhean
- St. Louis, MO64 sgrùdaidhean
- Queens, NY64 sgrùdaidhean
- Durham, NC64 sgrùdaidhean
- Chicago, IL59 sgrùdaidhean
- Philadelphia, PA56 sgrùdaidhean
- Dallas, TX55 sgrùdaidhean
Sgrùdaidhean eile ann an Ann Arbor
- Aillse Prostata27 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag26 sgrùdaidhean
- Aillse (gach seòrsa)25 sgrùdaidhean
- Ailseachadh nan Sgamhan23 sgrùdaidhean
- Aillse colorectal23 sgrùdaidhean
- Fàilligeadh a' Chridhe22 sgrùdaidhean
- Leukemia myeloid geur17 sgrùdaidhean
- Galarachd Cardiovasculach16 sgrùdaidhean
- Cancer Pancreatic14 sgrùdaidhean
- Melanoma12 sgrùdaidhean
- Buailteach12 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil12 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.